An environmental control system includes an air conditioning subsystem and a contaminant removal subsystem downstream of the environment to be conditioned. The contaminant removal subsystem includes: a first gas-liquid contactor-separator; a second gas-liquid contactor-separator; and a dehumidifier disposed either upstream of the first gas-liquid contactor-separator or downstream of the second gas-liquid contactor-separator.

A sterile solution product bag includes sterilization grade filter integrated directly into the product bag such that microbial and particulate matter filtration can be performed using the filter directly at the point of fill. The filter can include a hollow fiber filter membrane contained in a stem connected to a bladder of the product bag.

The invention pertains to a polyaryl ether sulfone polymer solution [solution (SP)] comprising: —at least one sulfone polymer [polymer (PSI)] having recurring units, wherein more than 50% moles, with respect to all the recurring units of polymer (PSI), are recurring units (R.sub.PSI) selected from the group consisting of those of formulae (R.sub.PSI-1) and (R.sub.PSI-2) herein below: (R.sub.PSI-1) (R.sub.PSI-2) wherein: —each of E′, equal to or different from each other and at each occurrence, is selected from the group consisting of those of formulae (E′-1) to (E′-3): (E′-I) (E′-II) (E′-III) —each R′ is independently selected from the group consisting of halogen, alkyl, alkenyl, alkynyl, aryl, ether, thioether, carboxylic acid, ester, amide, imide, alkali or alkaline earth metal sulfonate, alkyl sulfonate, alkali or alkaline earth metal phosphonate, alkyl phosphonate, amine and quaternary ammonium; and —j′ is zero or an integer of 1 to 4; is a bond or a divalent group optionally comprising one or more than one heteroatom; preferably T is selected from the group consisting of a bond, —CH.sub.2—, —C(O)—, —C(CH.sub.3).sub.2—, —C(CF.sub.3).sub.2—, —C(═CCI.sub.2)—, —C(CH.sub.3)(CH.sub.2CH.sub.2—COOH)—, and a group of formula: (A) —at least one polar organic solvent [solvent (S)]; and —at least one mixture of polyhydroxyl aliphatic alcohols having from 1 to 6 carbon atoms or derivatives thereof [mixture (PHA)], said mixture (PHA) comprising at least one ethylene glycol compound [compound (EthyGly)] and at least one glycerol compound [compound (Gly)], to its use for manufacturing membranes, and to membranes obtained therefrom. ##STR00001##

The present disclosure relates to a process for manufacturing a sterilizing filter comprising a plurality of hollow fiber membranes having a large inner diameter.

The invention relates to a method for preparing a hierarchical porous zeolite membrane and an application thereof, comprising the following steps: a mesoporous structure-directing agent is added to limit the growth of zeolite crystals, and self-assembled in the crystallization process to generate a mesoporous structure. Based on a seed crystal induced secondary nucleation mechanism, this method can realize one-step hydrothermal synthesis of hierarchical porous zeolite membrane with the advantages of mild and controllable synthesis conditions, simple process, good repeatability, reduced energy consumption and cost savings. The hierarchical porous zeolite membrane prepared by the method has good cut-off performance, and the cut-off molecular weight is adjustable between 200 to 500,000 Da.

A fluid separation apparatus comprising a fluid separation membrane is provided. The fluid separation apparatus comprises a fluid separation membrane extending in one direction and having a cross-section with a closed curve shape, wherein the fluid separation membrane has a thickness of 0.1 mm to 2 mm, and an outer diameter of 60 mm to 360 mm when the cross-section is adjusted to be circular.

A virus removal membrane includes cellulose, and a primary-side surface through which the protein-containing solution is to be applied and a secondary-side surface from which a permeate that has permeated the virus removal membrane is to be flowed, wherein a bubble point is 0.5 MPa or more and 1.0 MPa or less; and when a solution containing gold colloids having a diameter of 30 nm is applied through the primary-side surface to the virus removal membrane to allow the virus removal membrane to capture the gold colloids for measurement of brightness in a cross section of the virus removal membrane, a value obtained by dividing a standard deviation of a value of an area of a spectrum of variation in the brightness by an average of the value of the area of the spectrum of variation in the brightness is 0.01 or more and 0.30 or less.

The invention relates generally to methods of improving function of a transplanted organ, treating or preventing primary graft dysfunction of a transplanted organ, treating or preventing acute rejection of a transplanted organ, treating or preventing delayed graft function, or achieving a clinical endpoint indicative of a successful organ transplant in a recipient of the transplanted organ which comprise contacting blood from the recipient with an extracorporeal membrane having a plurality of pores having an average pore size of at least 40 kDa, 50 kDa or 60 kDa to permit inflammatory cytokines and other inflammatory molecules to pass through the pores and out of the blood that is returned back to the recipient.

There is provided a membrane comprising: a porous support layer having a first surface and a second surface; a palladium (Pd)-based selective layer on a first surface of the support layer; and a zeolite protective layer on a second surface of the support layer, wherein the support layer is between the Pd-based selective layer and the zeolite protective layer. There is also provided a method of forming the same.

Flow capture device and method for removing cells from blood The current invention discloses a blood treating and/or purifying device for removing circulating pathogens, preferably pathogenic cells, more preferably circulating tumor cells from the blood of a patient, a method of producing such a device and method to treat cancer and other diseases caused by virus infection, bacterial infection and parasites infection as well as autoimmune disorders. The described method is an extracorporeal medical therapy, thus can be done also in a hemodialysis system. The current invention also describes a device and an in-situ production method of preparing the device to remove CTC and other pathogens i.e. virus, bacteria or parasites from the bloodstream.